7F7FResponsible DepartmentDepartment of Stem Cells and Applied MedicineResearch PartnerROHTO Pharmaceutical Co., Ltd.Responsible DepartmentDepartment of Advanced Device Regenerative MedicineResearch PartnerMenicon Co. Ltd.262607010703Regenerative medicine based on stem-cell technology can possibly treat irreversibly dysfunctional tissues or organs that medicine cannot treat currently. However, the realization of regenerative medicine has faced some significant obstacles, such as cell preparation methods, product standardization, and the costs of manufacturing. The aim of our department is to develop new technologies to manufacture and standardize stem-cell-based products for the advancement of regenerative medicine.We are aiming to develop innovative medical devices by using a new self-assembling peptide gel developed with nanotechnology. The self-assembling peptide gel has high transparency under neutral condition and acts as a scaffold. The development of medical devices with the self-assembling peptide gel is mainly focused on ophthalmology field where transparency is important. Specifically, we will develop auxiliary materials for surgeries and tissue regeneration. We also aim to develop new drugs for corneal regenerative medicine.B-12A-34SAKIMOTO SusumuEndowed Chair Associate ProfessorDepartment of Stem Cells and Applied MedicineNISHIDA KohjiProfessorDepartment of OphthalmologyDevelopment of new technology for the manufacturing, standardization and application of stem cell-based productsDevelopment of Innovative Medical Devices using Bionanotechnology and drug development for corneal regeneration medicine
元のページ ../index.html#27